ACB
Aurora CannabisACB
ACB
About: Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
Employees: 1,101
0
Funds holding %
of 7,310 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
106% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 18
67% more capital invested
Capital invested by funds: $20.6M [Q4 2024] → $34.5M (+$13.8M) [Q1 2025]
5.49% more ownership
Funds ownership: 8.84% [Q4 2024] → 14.33% (+5.49%) [Q1 2025]
3% less call options, than puts
Call options by funds: $4.19M | Put options by funds: $4.32M
6% less funds holding
Funds holding: 165 [Q4 2024] → 155 (-10) [Q1 2025]
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
Research analyst outlook
We haven’t received any recent analyst ratings for ACB.
Financial journalist opinion
Based on 21 articles about ACB published over the past 30 days
Neutral
PRNewsWire
13 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
PRNewsWire
5 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
PRNewsWire
5 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
PRNewsWire
6 days ago
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ | TSX: ACB EDMONTON, AB , June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from $40,000 to $60,000 CAD for Aurora patients through AuroraMedical.com.
Neutral
PRNewsWire
1 week ago
Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB , June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new proprietary cultivars in Poland, marking the highest potency medical cannabis products available in the country. Grown and manufactured in the company's Canadian GACP and EU-GMP facilities, the premium dried medical cannabis products Farm Gas and Sourdough are crafted with precision and expertise to deliver a superior, high THC flower.
Negative
Seeking Alpha
1 week ago
Aurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 Revenues
Aurora Cannabis recently reported improved Q4-2025 results. ACB's international medical cannabis sales are increasing revenues. The company reported record revenues, but low gross profit and weak 2026 outlook.
Neutral
MarijuanaStocks
1 week ago
3 Cannabis Stocks For Investors To Secure For Future Gains
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, there has been a sharp decline in the overall trading for most top marijuana stocks. Now, you would think that with the sector down and showing no true signs of recovery, all is lost. That is not the case, as most companies are making money and having a positive impact.
Neutral
PRNewsWire
1 week ago
Aurora Cannabis Advises of Second False Article from Investing.com
NASDAQ | TSX: ACB EDMONTON, AB , June 19, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on news website, Investing.com. On June 18, 2025, Aurora advised the market that an article posted on Investing.com incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics.
Neutral
PRNewsWire
2 weeks ago
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics
NASDAQ | TSX: ACB EDMONTON, AB , June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of misinformation posted on a news website, incorrectly stating that Aurora has agreed to acquire New Zealand based MedLeaf Therapeutics. The Company has not entered into any such agreement, has had no discussions with MedLeaf Therapeutics with respect to any business combination transaction, and has not made any statement or filed any information pertaining to any such transaction.
Negative
Seeking Alpha
2 weeks ago
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)
Aurora Cannabis reported mixed Q4/FY2025 results, with higher-than-expected revenues offset by lower profitability due to a number of one-time expenses. Following substantial growth in recent quarters, medical cannabis sales were essentially flat on a quarter-over-quarter basis. On the conference call, management admitted to headwinds from recent regulatory changes in Poland. As a result, medical cannabis sales and profitability are expected to decline in Q1/FY2026.
Charts implemented using Lightweight Charts™